Report cover image

Asia Pacific CRDMO Market

Publisher BlueWeave Consulting
Published Oct 01, 2025
Length 268 Pages
SKU # BLWC20706873

Description

Asia Pacific CRDMO Market, By Service Type (Drug Discovery, Preclinical Development, Clinical Development, and Commercial Manufacturing); By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Disorders, Neurology); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutes); By Country (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2031Asia Pacific CRDMO Market to Reach USD 120.96 Billion by 2031

Asia Pacific CRDMO (Contract Research, Development, and Manufacturing Organization) Market is booming primarily due to rising pharma outsourcing, biologics demand, skilled workforce, cost efficiency, supportive policies, and expanding clinical trials.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Asia Pacific CRDMO (Contract Research, Development, and Manufacturing Organization) Market size by value at USD 60.13 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Asia Pacific CRDMO Market size to boom at a robust CAGR of 10.50%, reaching a value of USD 120.96 billion by 2031. The expansion of Asia Pacific CRDMO Market is driven by rising pharmaceutical and biotech outsourcing, cost-effective operations, and a highly skilled workforce. Growing demand for biologics, biosimilars, and personalized medicine fuels integrated service needs across drug development stages. Government incentives, expanding healthcare infrastructure, and increasing clinical trial activity enhance regional appeal. Countries like China, India, and South Korea offer scalable capacity, regulatory adaptability, and advanced R&D capabilities, making them preferred destinations for global pharma collaborations and accelerating the growth of Asia Pacific CRDMO Market in the coming years.

Opportunity – Strategic Partnerships with Global BioPharma Companies

Strategic collaborations between Asia Pacific CRDMOs and global pharmaceutical companies are a key growth driver, enhancing innovation, scalability, and market access. These partnerships enable technology transfer, regulatory alignment, and accelerated drug development timelines. Countries like China, India, and South Korea offer cost-effective, high-quality services, attracting multinational firms seeking integrated solutions. Joint ventures and long-term alliances strengthen regional capabilities, foster trust, and position the players in Asia Pacific CRDMO Market as vital in the global pharmaceutical value chain.

Commercial Manufacturing Segment Holds Largest Market Share

The commercial manufacturing segment is the largest service in Asia Pacific CRDMO Market. The segment’s market dominance is driven by an increasing demand for scalable, cost-effective drug production. Pharmaceutical companies outsource manufacturing to leverage advanced infrastructure, regulatory expertise, and efficient supply chains across countries like China and India. The rise of biologics and biosimilars further boosts this segment, requiring specialized capabilities and high-volume output. As global pharma seeks reliable partners, Asia Pacific CRDMOs play a pivotal role in meeting commercial-scale production needs.

Impact of Escalating Geopolitical Tensions on Asia Pacific CRDMO Market

Escalating geopolitical tensions pose challenges to the growth of Asia Pacific CRDMO Market by disrupting global supply chains, complicating cross-border collaborations, and increasing regulatory scrutiny. Trade restrictions and export controls can delay drug development timelines and hinder access to critical materials. Countries like China and India may face heightened compliance demands from international partners. To mitigate risks, CRDMOs are diversifying sourcing strategies, strengthening regional capabilities, and investing in regulatory resilience, ensuring continuity and competitiveness amid shifting global dynamics and strategic realignments.

Competitive Landscape

Asia Pacific CRDMO Market is highly fragmented, with numerous players serving the market. Major companies dominating the market are WuXi AppTec, Samsung Biologics, Lonza Group, Syngene International, Piramal Pharma Solutions, Jubilant Biosys, Asymchem Laboratories, Boehringer Ingelheim, Thermo Fisher Scientific, Charles River Laboratories, and Labcorp Drug Development. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in Asia Pacific CRDMO Market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Asia Pacific CRDMO Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Asia Pacific CRDMO Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

268 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Asia Pacific CRDMO Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising R&D Expenditure in Pharma and Biotech
3.2.1.2. Expansion of Biologics and Advanced Therapies
3.2.1.3. Cost-Effective Manufacturing and Skilled Workforce
3.2.2. Restraints
3.2.2.1. Regulatory Complexity Across Regional Markets
3.2.2.2. Limited Infrastructure in Emerging Economies
3.2.2.3. Intellectual Property Protection Concerns
3.2.3. Opportunities
3.2.3.1. Strategic Partnerships with Global Pharma Companies
3.2.3.2. Increasing Demand for High-Potency APIs
3.2.4. Challenges
3.2.4.1. Supply Chain Disruptions and Raw Material Dependency
3.2.4.2. Rapid Technological Advancements Requiring Constant Upgrades
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Asia Pacific CRDMO Market: Marketing Strategies
5. Asia Pacific CRDMO Market: Pricing Analysis
6. Asia Pacific CRDMO Market Overview
6.1. Market Size & Forecast, 2019–2031
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Service Type
6.2.1.1. Drug Discovery
6.2.1.2. Preclinical Development
6.2.1.3. Clinical Development
6.2.1.4. Commercial Manufacturing
6.2.2. By Therapeutic Area
6.2.2.1. Oncology
6.2.2.2. Infectious Diseases
6.2.2.3. Cardiovascular Disorders
6.2.2.4. Neurology
6.2.3. By End User
6.2.3.1. Pharmaceutical Companies
6.2.3.2. Biotechnology Firms
6.2.3.3. Academic and Research Institutes
6.2.4. By Region
6.2.4.1. China
6.2.4.2. Japan
6.2.4.3. India
6.2.4.4. Australia
6.2.4.5. South Korea
6.2.4.6. Rest of Asia Pacific
7. Competitive Landscape
7.1. List of Key Players and Their Offerings
7.2. Asia Pacific CRDMO Market Company Market Share Analysis, 2024
7.3. Competitive Benchmarking, By Operating Parameters
7.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
8. Impact of Escalating Geopolitical Tensions on Asia Pacific CRDMO Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
9.1. WuXi AppTec
9.2. Samsung Biologics
9.3. Lonza Group
9.4. Syngene International
9.5. Piramal Pharma Solutions
9.6. Jubilant Biosys
9.7. Asymchem Laboratories
9.8. Boehringer Ingelheim
9.9. Thermo Fisher Scientific
9.10. Charles River Laboratories
9.11. Labcorp Drug Development
9.12. Other Prominent Players
10. Key Strategic Recommendations
11. Research Methodology
11.1. Qualitative Research
11.1.1.Primary & Secondary Research
11.2. Quantitative Research
11.3. Market Breakdown & Data Triangulation
11.3.1.Secondary Research
11.3.2.Primary Research
11.4. Breakdown of Primary Research Respondents, By Region
11.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Asia Pacific CRDMO Market Segmentation
Figure 2 Asia Pacific CRDMO Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2024
Figure 4 Asia Pacific CRDMO Market Size, By Value (USD Billion), 2019–2031
Figure 5 Asia Pacific CRDMO Market Share, By Service Type, By Value, 2019–2031
Figure 6 Asia Pacific CRDMO Market Share, By Therapeutic Area, By Value, 2019–2031
Figure 7 Asia Pacific CRDMO Market Share, By End User, By Value, 2019–2031
List of Tables
Table 1 Asia Pacific CRDMO Market Size, By Value (USD Billion), 2019–2031
Table 2 Asia Pacific CRDMO Market Size, By Service Type, By Value, 2019–2031
Table 3 Asia Pacific CRDMO Market Size, By Therapeutic Area, By Value, 2019–2031
Table 4 Asia Pacific CRDMO Market Size, By End User, By Value, 2019–2031
Table 5 Asia Pacific CRDMO Market Size, By Region, By Value, 2019–2031
Table 6 WuXi AppTec Company Overview
Table 7 WuXi AppTec Financial Overview
Table 8 Samsung Biologics Company Overview
Table 9 Samsung Biologics Financial Overview
Table 10 Lonza Group Company Overview
Table 11 Lonza Group Financial Overview
Table 12 Syngene International Company Overview
Table 13 Syngene International Financial Overview
Table 14 Piramal Pharma Solutions Company Overview
Table 15 Piramal Pharma Solutions Financial Overview
Table 16 Jubilant Biosys Company Overview
Table 17 Jubilant Biosys Financial Overview
Table 18 Asymchem Laboratories Company Overview
Table 19 Asymchem Laboratories Financial Overview
Table 20 Boehringer Ingelheim Company Overview
Table 21 Boehringer Ingelheim Financial Overview
Table 22 Thermo Fisher Scientific Company Overview
Table 23 Thermo Fisher Scientific Financial Overview
Table 24 Charles River Laboratories Company Overview
Table 25 Charles River Laboratories Financial Overview
Table 26 Labcorp Drug Development Company Overview
Table 27 Labcorp Drug Development Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us